Epilepsy and suicide: pathogenesis, risk factors, and prevention

Código QR

Epilepsy and suicide: pathogenesis, risk factors, and prevention

Alberto Verrotti1, Alessandra Cicconetti2, Barbara Scorrano2, Domenico De Berardis2,3, Carla Cotellessa2, Francesco Chiarelli1, Filippo Maria Ferro21Department of Pediatrics; 2Department of Oncology and Neuroscience, Institute of Psychiatry, University &ldquo;G. d&rsquo;Annunzio&...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Alberto Verrotti, Alessandra Cicconetti, Barbara Scorrano, Domenico De Berardis, Carla Cotellessa, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/9854f626869d49bb822666da145c1fa4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension
por: Amresh Shrivastava, et al.
Publicado: (2010)

Sotos syndrome and the added value of genetic workup in epilepsy surgery
por: Linda Bättig, et al.
Publicado: (2021)

Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?
por: Maurizio Pompili, et al.
Publicado: (2008)

Response: Sotos Syndrome and the added value of genetic workup in epilepsy surgery
por: Kenneth A. Myers
Publicado: (2021)

Psychiatric comorbidity and suicide risk in patients with chronic migraine
por: Maurizio Pompili, et al.
Publicado: (2010)

Monitoring And Managing Depression In Adolescents With Epilepsy: Current Perspectives
por: Coppola G, et al.
Publicado: (2019)

Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
por: Alla Avedisova, et al.
Publicado: (2009)

Synucleinopathy-associated pathogenesis in Parkinson’s disease and the potential for brain-derived neurotrophic factor
por: Kathryn M. Miller, et al.
Publicado: (2021)

The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
por: Madelyn C. Houser, et al.
Publicado: (2017)

The role of duloxetine in the treatment of anxiety disorders
por: Domenico De Berardis, et al.
Publicado: (2008)

SAFA: A new measure to evaluate psychiatric symptoms detected in a sample of children and adolescents affected by eating disorders. Correlations with risk factors
por: Emilo Franzoni, et al.
Publicado: (2009)

Precision antiplatelet therapy for the prevention of ischaemic stroke
por: David Wang

Neuropsychological effects of antiepileptic drugs (carbamazepine versus valproate) in adult males with epilepsy
por: Ghaydaa A Shehata, et al.
Publicado: (2009)

Recurrent schizophrenia-like psychosis as first manifestation of epilepsy: a diagnostic challenge in neuropsychiatry
por: Willem MA Verhoeven, et al.
Publicado: (2010)

Epilepsy and homicide
por: Pandya NS, et al.
Publicado: (2013)

Cilostazol for secondary stroke prevention: systematic review and meta-analysis
por: Leonard LL Yeo, et al.
Publicado: (2021)

The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism
por: Caroline M. Tanner, et al.
Publicado: (2021)

Management of epilepsy in the elderly
por: Juan Jos&eacute; Poza
Publicado: (2007)

Levetiracetam in the treatment of epilepsy
por: Bassel Abou-Khalil
Publicado: (2008)

Increased mRNA expression of cytochrome oxidase in dorsal raphe nucleus of depressive suicide victims
por: A Sanchez-Bahillo, et al.
Publicado: (2008)

Epilepsy and violence: case series concerning physical trauma in children of persons with epilepsy
por: Gauffin H, et al.
Publicado: (2014)

First true initial ictal SPECT in partial epilepsy verified by electroencephalography
por: Jes&uacute;s Pastor, et al.
Publicado: (2008)

Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
por: Lei Zhang, et al.
Publicado: (2021)

Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy
por: Tambucci R, et al.
Publicado: (2016)

Pregabalin for the management of partial epilepsy
por: Philippe Ryvlin, et al.
Publicado: (2008)

Pregabalin in the management of partial epilepsy
por: Amir M Arain
Publicado: (2009)

Update on rufinamide in childhood epilepsy
por: Coppola G
Publicado: (2011)

Temporal Lobe Epilepsy and Psychiatric Comorbidity
por: Valerio Vinti, et al.
Publicado: (2021)

Assessing suicidal risk with antiepileptic drugs
por: Marco Mula, et al.
Publicado: (2010)

The role of the serotonergic system in suicidal behavior
por: Sadkowski M, et al.
Publicado: (2013)

Reasons for reoperation after epilepsy surgery: a review based on a complex clinical case with three operations
por: Jos&eacute; F T&eacute;llez-Zenteno, et al.
Publicado: (2010)

Topiramate in the treatment of partial and generalized epilepsy
por: Edward Faught
Publicado: (2007)

Monotherapy for partial epilepsy: focus on levetiracetam
por: Antonio Gambardella, et al.
Publicado: (2008)

Animal models of epilepsy: use and limitations
por: Kandratavicius L, et al.
Publicado: (2014)

Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
por: Philippe Courtet
Publicado: (2010)

Utility and Safety of Perampanel in Pediatric FIRES and Other Drug-Resistant Epilepsies
por: Guo Yong Lim BSc(Pharm.)(Hons.), et al.
Publicado: (2021)

Profile of brivaracetam and its potential in the treatment of epilepsy
por: Ferlazzo E, et al.
Publicado: (2015)

Posttraumatic epilepsy: current and emerging treatment options
por: Paiva WS, et al.
Publicado: (2014)

New developments in the treatment of partial-onset epilepsy
por: Besag FM, et al.
Publicado: (2012)

Brain-derived neurotrophic factor: role in depression and suicide
por: Yogesh Dwivedi
Publicado: (2009)